[{"Assets_0_Q1_USD":1527380000.0,"CommonStockSharesOutstanding_0_Q1_shares":37409328.0,"EarningsPerShareBasic_1_Q1_USD":0.42,"EarningsPerShareDiluted_1_Q1_USD":0.42,"NetCashProvidedByUsedInOperatingActivities_3_Q1_USD":44696000.0,"NetIncomeLoss_3_Q1_USD":15863000.0,"NetIncomeLoss_1_Q1_USD":15863000.0,"StockholdersEquity_0_Q1_USD":959810000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":37705000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":37376000.0,"Ticker":"TECH","CIK":"842023","name":"BIO-TECHNE CORP","OfficialName":"Bio-Techne Corp Common Stock","form":"10-Q","period":"20170930","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16235870966.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"SP500","filed":"20171109"}]